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REVIEW CURRENTOPINION Reappraising Starling: the physiology of
the microcirculationopyright © Lippincott Will
www.co-criticalcare.comMatthias Jacob and Daniel ChappellPurpose of review
Vascular permeability is traditionally explained by Starling’s principle, describing two opposing forces
across the endothelial cell line to maintain compartments in balance. Several contradictions to this principle
have recently questioned its validity.
Recent findings
Hydraulic conductivity is kept low by a properly working endothelial surface layer, created by binding and
intercalating plasma constituents with the structural elements of an endothelial glycocalyx. Limiting fluid
filtration is not closely related to the interstitial protein concentration. Rather, the oncotic pressure difference
pertinent to fluid homeostasis is built up between the intravascular space and a small protein-free zone
beneath the protein-loaded endothelial glycocalyx. This crucial structure, and therefore the resistance of the
barrier against outflow of large molecules, is endangered by ischaemia, inflammation and intravascular
hypervolaemia. An intact endothelial surface layer retains iso-oncotic preparations of large molecules
infused to compensate for acute bleeding. Crystalloids cannot be held back sufficiently, even if preload is
warranted.
Summary
Starling’s principle requires an adaptation to recognize that there is no inward-directed oncotic pressure
gradient across the whole anatomical vessel wall. The carrier of vascular barrier competence is the intact
endothelial surface layer which might be protected by avoiding intravascular hypervolaemia and limiting
inflammation.
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The target of circulatory therapy is the microcircu-
lation. Unfortunately, despite promising efforts [1
&
],
it still cannot be reliably assessed in clinical routine.
This frequently leads to disregarding it in clinical
practice, focusing treatment on cardio-circulatory
surrogates. However, the ‘stabilized’ critically ill
patient often bares surprises of what actually hap-
pens below the surface [2]. Despite the fact that
appropriate surrogates combined to a pragmatic
approach can be successful, some patients might
benefit from a better understanding of the physio-
logy of compartments and barriers.Germany
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Protozoa consist merely of one compartment which
is directly in touch with the environment; they do
not need a circulation. During evolution, single cells
were organized to organs and higher organisms.iams & Wilkins. UnauthoThis is a problem for the nutrition of parenchymal
cells which are now sealed within a body, far away
from the substrates. The formerly unlimited extra-
cellular space is now dramatically reduced to a
closed compartment (‘interstitium’), being quickly
overwhelmed by cell metabolism if not perma-
nently disposed and supplied. Nature has assigned
this latter mission to the circulation. Cardiac arrest
impressively demonstrates what happens if this sys-
tem fails. The anatomical basis, the intravascular
compartment, is part of the extracellular space,rized reproduction of this article is prohibited.
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KEY POINTS
 The endothelial glycocalyx covers the entire vascular
lumen of healthy blood vessels and forms an
endothelial surface layer by binding plasma
constituents.
 The vascular barrier consists anatomically of the
endothelial cell line and the endothelial surface layer.
 The carrier of physiological vascular barrier
competence is the endothelial surface layer as the
inward-directed oncotic pressure gradient is derived
across the glycocalyx.
 If the vascular barrier is intact, iso-oncotic preparations
have a volume effect far beyond that of crystalloids.
 Sepsis, ischaemia, diabetes, arteriosclerosis, trauma





FIGURE 1. The vascular system is under (blood) pressure
(white arrows), which is, according to the traditional view,
opposed by the inward-directed oncotic gradient (grey
arrows) generated across the vascular wall by a difference
in the protein (grey circles) concentration.
The physiology of microcirculation Jacob and Chappellfunctionally separated from the rest by the vascular
barrier.
The water content of healthy, normal weight
adults lies around 60% (45 l) under steady-state
conditions. About 2/3 (30 l) is stored intracellularly,
whereas 1/3 (15 l) forms the extracellular compart-
ment. The latter consists by 80% (12 l) of the inter-
stitial space and contributes by 20% (3 l) as plasma
to cardiac preload. Water distribution between these
two compartments is driven by hydrostatic press-
ures and the distribution of osmotically and oncoti-
cally active substances. Water by itself is not
retained at any barrier within the human body.
External heart work permanently generates a
longitudinal hydrostatic gradient from the heart
via the arterial site across the microcirculation
towards the large veins and back to the heart, sus-
taining blood flow. At the same time, this (blood)
pressure permanently tries to force blood com-
ponents across the vascular barrier towards the
interstitial space, especially in the arterial system
(Fig. 1). Under physiological conditions this is pre-
vented by an intact vascular barrier.ERNEST STARLING’S HISTORICAL
CONCEPT: A HIGH FILTRATION–
REABSORPTION SCENARIO
In 1896, Ernest Starling [3] published his model of
microvascular fluid dynamics. On the basis of the
available knowledge at this time, he suggested the
endothelial cell line to resist the hydrostatically
driven outflow of plasma constituents. Addition-
ally, Starling presumed a protein-poor interstitial
space, schematically drafting an oncotic gradientCopyright © Lippincott Williams & Wilkins. Unau
1070-5295  2013 Wolters Kluwer Health | Lippincott Williams & Wilkback towards the protein-rich plasma, binding water
intravascularly and opposing the outwards directed
force.
According to Ernest Starling [3], filtration
behaviour across the vascular barrier of a non-fenes-
trated microvessel is traditionally described by the
following equation:
F¼HC [(PVPI) (pVpI)]
where F is the filtration rate per unit area per time;
HC the hydraulic conductivity of the vascular bar-
rier (amount per pressure per time); PVPI the
hydrostatic pressure P difference between the vas-
cular lumen V and the interstitial space I; pVpI
is the oncotic pressure p difference between the
vascular lumen and the interstitial space.
The story of Ernest Starling, ignoring the dis-
pensable reflection coefficient for proteins, is that of
two competing pressure gradients and the physical
resistance of the vascular barrier against water
passage. In this theory, the type of protein or
colloid which is active at the endothelial surface
is irrelevant, it exclusively calculates with colloid
osmotic pressure (COP). ‘Hydraulic conductivity’,
represented by the angle alpha, is an intrinsic prop-
erty of the barrier itself and has nothing to do with
additional forces. Principally, an increasing hydro-
static pressure gradient (PVPI; X-axis) across a
biological membrane leads to an increase in the
filtration rate (Y-axis), the intersection lying in
the point of origin (Fig. 2, black graph) [4].
Additionally, considering Starling’s suggestion
of an opposing inward-directed oncotic force across
the whole anatomical vessel wall does not change
hydraulic conductivity (graph steepness), but moves




























FIGURE 2. Net filtration behaviour across a non-fenestrated
biological barrier when considering only a hydrostatic
gradient (black graph) or with an additional inward directed
force (grey graph). F, filtration rate per unit area;
intersection i, net force opposed to the outward-directed
hydrostatic gradient; PV PI, hydrostatic pressure difference
between the vascular lumen and the interstitial space
(adapted with permission from [4]).
Intravenous fluidsintersection ‘i’ with the abscissa represents the net
force opposed to the outward-directed hydrostatic
gradient. The outward-directed force has to exceed
the inward-directed force to start fluid filtration.
Beyond that point, Dfiltration rate per Dhydrostatic
pressure is the same as without. However, if the
intravascular hydrostatic pressure falls below ‘i’ –
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FIGURE 3. The filtration behaviour presumed by Ernest Starling
pressure gradient. Grey line: colloid osmotic pressure gradient (a
284 www.co-criticalcare.comthe venular aspect – then fluid should be reabsorbed
back into the intravascular space, which is an
important part of this historical principle.
Following Starling’s theoretical considerations,
the two competing forces at the vascular wall might
result in net filtration of water and small molecules
towards the interstitial space in the high-pressure
arteriolar segment. In the venular aspects, the
inward-directed force should exceed the locally
low intravascular pressure and most of the filtered
volume is reabsorbed, obviously after a kind of fluid
bypass across the interstitial space. Lymphatic drain-
age of any excess should keep the tissues in balance
(Fig. 3) [5].
Increasing evidence from the past decade, how-
ever, revealed several contradictions to this histori-
cal model, indicating that it might require an update
[6
&
].THE FIRST CONTRADICTION TO
STARLINGS PRINCIPLE
One of Starling’s basic presumptions is a protein-low
area beyond the vascular barrier. This presumption
does not reflect reality; the interstitial space is
packed with albumin [7]. Already in 1991, Levick
[8] formulated his ‘low lymph flow paradox’. It was
based on observations that most tissues would not
be in balance if the inward-directed oncotic gradient
across the vascular wall would be the only force
limiting net pressure-dependent fluid filtration
[9]. Adamson et al. [4] provided a quantitative idea
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FIGURE 4. Pressure dependence of transudate formation in
guinea pig hearts when perfusing the coronary system with
a protein-free Krebs–Henseleit buffer (black graph) or
when adding sub-physiological doses of human albumin
(1 g%, grey graph) (published with permission from [10]).
The physiology of microcirculation Jacob and Chappellmodel they modified the oncotic pressure within
the medium around, their model ‘interstitial space’.
They observed that a protein-free interstitial space –
as suggested by Ernest Starling – was related to the
expected pressure-dependent filtration behaviour
across the vascular wall (cf. Fig. 2, grey graph).
Obviously, an inward-directed force limiting pres-
sure-dependent fluid filtration was active. Surpris-
ingly, adapting the oncotic pressure of the artificial
interstitium to the intravascular pressure did not
relevantly change the conditions: the remaining
intersection with the abscissa (‘i’) indicates a force
opposing the intravascular pressure and limiting the
model lymph flow. Obviously, nature does not fit
into the historical equation of Ernest Starling,
suggesting unlimited pressure-dependent fluid
filtration for a failure of (pVpI) [3]. Rather, inde-
pendently of pI, the barrier works.
The force limiting pressure-dependent fluid filtration
is independent of the interstitial protein concentration.THE SECOND CONTRADICTION TO
STARLING’S PRINCIPLE
When describing the mechanism of action of intra-
vascular proteins and colloids, traditionally only
oncotic gradients are considered. This sight appears
to be incomplete; the interaction of intravascular
macromolecules with the endothelial surface is
much more complex. In the coronary system of
isolated guinea pig hearts, perfusion with a
colloid-free perfusate led to high transvascular fluid
shifts [10]. As expected, adding artificial colloids
enhanced vascular barrier competence. This effect,
however, was clearly inferior to perfusion even
with low concentrations of human albumin. The
graph representing pressure-dependent net fluid
filtration was not primarily shifted towards the
right. Remarkably, and quantitatively much more
important, albumin in sub-physiological concen-
trations (1 g%, 1/4 of the physiological concen-
tration) lowered hydraulic conductivity, flattening
the curve (Fig. 4). This observation was independent
of the intravascular existing COP, an effect termed
the ‘COP paradox’ [7].
The intravascular presence of a low concentration
of albumin does not primarily add another force to the
system but gears into the central barrier immanent
property ‘hydraulic conductivity’.THE THIRD CONTRADICTION TO
STARLING’S PRINCIPLE
Already in 1653, Olaus Rudbeck showed that lym-
phatic fluid contains all clotting factors and is
able to coagulate [11]. Meanwhile, it has beenCopyright © Lippincott Williams & Wilkins. Unau
1070-5295  2013 Wolters Kluwer Health | Lippincott Williams & Wilkdemonstrated that tissue factor, a potent initiator
of coagulation, is highly concentrated around high
pressure segments of the microcirculation [12–14].
The biological intention is most likely the formation
of a ‘haemostatic envelope’, immediately sealing the
arterioles in case of injury [15]. Under physiological
conditions, tissue factor is sufficiently separated
from the flowing blood [16]. On the one hand, an
excellent defensive strategy, on the other contra-
dicting Starling’s view of arterio-venular shifting, as
a bypass of coagulation factors would plug the inter-
stitial compartment with fibrin. Meanwhile, it has
been confirmed that a fluid transfer across the inter-
stitial space under physiological conditions is
unlikely [4]: fluid is not reabsorbed at the venular
aspect, but filtered at a variable extent throughout
the vasculature. Fluid excesses are returned exclu-
sively via the lymphatic system back into the circu-
lation [9].
An aterio-venous fluid bypass across the tissues does
not comply with the available data.THE VASCULAR BARRIER: AN UPDATE
The past decade brought astonishing new insights
into the biology of the vascular barrier, beyond the
well known existence of the endothelial cell line.
Obviously, the whole endothelial surface is covered
by a glycocalyx [5,17–20]. In 1966, first electron-
microscopical pictures appeared, but an insufficient
fixation technique led to its underestimation in size
and importance [21]. Fifteen years later, a ‘fibre-
matrix model of capillary permeability’ [22] was
established before Pries et al. [19] introduced their
ideas about an ‘endothelial surface layer’, presum-
ably carrying most of the vascular barrier compe-
tence. Modern fixation techniques for electronthorized reproduction of this article is prohibited.
ins www.co-criticalcare.com 285
C



















FIGURE 5. The revised model of vascular barrier
functioning. Within the high-pressure segments (PV PI) a
tight endothelial surface layer guarantees a low hydraulic
conductivity and the low oncotic pressure directly beneath
the layer counts as opposed to that within the distribution
space of the blood cells (pVpg; left-hand panel), the
resulting net outflow (small dotted arrows) being minimal.
Intravenous fluidsmicroscopy revealed a true thickness of the endo-
thelial glycocalyx of up to 1 mm [23]. Beyond
vascular barrier functioning, other important pro-
perties like anti-inflammation [2] and shear-stress
transduction to the endothelial surface [24] have
been attributed to this structure.
The endothelial glycocalyx is composed of
membrane-bound glycoproteins and proteoglycans,
mainly syndecan and glypican, carrying negatively
charged side chains (mainly heparan, but also der-
matan and chondroitin sulphates) and hyaluronan
[5,19,20]. The glycocalyx itself, however, is nothing
more than a skeleton. In vivo, by binding plasma
constituents (mainly albumin), it is completed to
the endothelial surface layer [5,19]. Only this entire
structure is biologically active as a vascular barrier
deserving this denomination, integrating the
minimal possible hydraulic conductivity [10] and
an adequate capacity to hold back large plasma
molecules, providing a filtration-limiting inward-
directed oncotic force. The site of this gradient
appears to lie completely on the luminal side of
the anatomical vessel wall [4,7].At the venular segment, by contrast, hydraulic conductivity
is high, but due to the locally low hydrostatic pressure,
diffusion into both directions (small black arrows) but not
much net outflow results (right hand panel) adapted with
permission from [5,7]. EC, endothelial cell line; ESL,
endothelial surface layer; IS, interstitial space; P, hydrostatic
pressure; p, oncotic pressure; I, within the interstitial space;
V, within the vascular lumen; g, within the protected region
below the ESL.THE VASCULAR BARRIER WITHIN THE
MICROCIRCULATION: A COMPLEX AND
FRAGILE SYSTEM
The available evidence commends that filtration
behaviour in arterioles and capillaries is principally
different from that across the wall of venules (Fig. 5).
The endothelial surface layer limits filtration mainly
within the high-pressure segments: hydrostatically
outward-driven plasma components are retained
here at the intact glycocalyx, increasingly loading
it with COP [7]. Therefore, the glycocalyx acts like a
sponge, separating large proteins from the ultrafil-
trate. This generates a ‘protected region’ of some
tens of nanometres with a very low protein concen-
tration directly beneath the glycocalyx, but com-
pletely on the luminal side of the endothelial cells
[5]. The latter are connected by tight junctions,
principally not allowing water passage but being
repeatedly interrupted by discontinuities within
the junction stand [4], conducting the protein-poor
ultrafiltrate towards the interstitial space. This per-
manently cleans the ‘protected region’ and prevents
a back diffusion of proteins towards this sub-glyceal
space, maintaining the inward-directed gradient
[25]. Therefore, the intravascular COP only shifts
pressure-dependent filtration behaviour to the right
(cf. Fig. 2) within the high-pressure segment and on
the basis of an intact endothelial surface layer,
additionally keeping hydraulic conductivity low
[7]. According to experimental evidence, the latter
condition should be given even at plasma albuminopyright © Lippincott Williams & Wilkins. Unautho
286 www.co-criticalcare.comconcentrations of 1 g%. However, there are no
clinical data evaluating such a threshold in human
patients.
Within the venular aspect, the system might be
much more penetrable for large molecules. As the
hydrostatic force here is low, this should not cause a
quantitative problem. Despite the fact that no ven-
ular net reabsorption occurs, extravasation of hor-
mones, vitamins, lipoproteins and so on to supply
the tissues is no problem, including back diffusion
towards the vasculature [7]. Fluid filtered from any
part of the circulatory system can be brought back
towards the circulation via the lymphatic system. If
its capacity is exceeded, interstitial oedema occurs.
Unfortunately, many patho-physiological situ-
ations in the perioperative and ICU setting are able
to deteriorate this fragile structure. Sepsis, ischae-
mia/reperfusion, diabetes, trauma, resuscitation and
arteriosclerosis have been shown to have a dramatic
impact on the integrity of the glycocalyx [26–30].
Several inflammatory mediators have been shownrized reproduction of this article is prohibited.
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The physiology of microcirculation Jacob and Chappellto compromise the glycocalyx [31–33]. But also
surgical trauma, inflammation and iatrogenic intra-
vascular hypervolaemia endanger vascular barrier
competence [34].FLUID PHYSIOLOGY MEETS CLINICAL
PRACTICE: THE TRUTH ABOUT VOLUME
EFFECTS
Recent clinical evidence around the efficacy of
infusion measures fits impressively into these new
physiological insights. In principle, two different
model situations are of interest when intravenously
applying i.v. fluids: infusion to maintain or restore
blood volume in the context of acute bleeding, that
is, when the system is in need of volume (clinical
model: acute normovolaemic haemodilution –
ANH [35]) and infusion in order to expand blood
volume beyond intravascular normovolaemia,
that is, when the system is not in need of volume
(clinical model: hypervolaemic haemodilution
[36]). Whereas the clinical impression including
changes in haematocrit is occasionally misleading
[37], only the combination of haemodilutional
measures with direct assessment of the blood vol-
ume before and after can determine the intravascu-
lar volume effect. This was done prospectively for
ANH with lactated Ringer and iso-oncotic pre-
parations of human albumin and hydroxyethyl
starch (Table 1) [35,38,39
&&
,40]. As expected, the




The physiological reason should be primarily a
dilution of the intravascular oncotic pressure (pV),
increasing filtration mainly at the arteriolar site by
shifting the pressure-dependent fluid filtration to the
left. Perhaps a transient increase of the intravascular
hydrostatic pressure (PV) affecting the whole system
might also play a role here. Therefore, Starling was
quantitatively absolutely right: the target compart-
ment of an isotonic crystalloid is the extracellularCopyright © Lippincott Williams & Wilkins. Unau






ANH 5% Human albumin 15 3.745313 1.150
10 4.412588 1.576
6% HES 130/0.4 10 4.142474 1.431
6% HES 200/0.5 10 4.093491 1.269
Lactated Ringer 10 3.959387 1.097
VL 5% Human albumin 10 4.189769 n/a
6% HES 200/0.5 10 4.215728 n/a
Values are meanSD. ANH, actue normovolaemic haemodilution; HES, hydroxyeth
1070-5295  2013 Wolters Kluwer Health | Lippincott Williams & Wilkspace. Also a hypovolaemic circulation requiring
restoration of cardiac preload is not able to retain
oncotic pressure-free fluid. This ‘type I shift’ [34] is
the predictable result of a chosen therapeutical con-
cept and not associated with an alteration of the
vascular barrier.
All tested iso-oncotic solutions, by contrast,
remained almost completely within the circulatory
compartment if infused to replace losses by acute
bleeding [35].
Obviously, by more or less maintaining pre-
existing pressures around an intact vascular barrier
by infusing iso-oncotic preparations during acute
bleeding no relevant shift is induced.
Colloidal intravascular hypervolaemia, by con-
trast, led to a reduced intravascular volume effect of
around 40% of the infused amount, 60% loaded the
interstitial compartment as oedema [36]. This appli-
cation of iso-oncotic colloids outside a proper
indication significantly reduced the total volume
of the endothelial surface layer to 1/3 of the initial
value, presumably representing a severe affection of
vascular biology.
Intravascular hypervolaemia causes a release of
ANP, inducing matrix metalloproteases [41] digest-
ing the endothelial glycocalyx within a very short
period of time. The observed marked ‘type II shifting’
[34] of protein-rich fluid towards the interstitial space
is the clinical correlate of a significantly altered vas-
cular barrier. This increases hydraulic conductivity
and decreases the force opposing to the outflow of
proteins by increasing the oncotic pressure below the
endothelial glycocalyx (pg) – a severe pathophysio-
logical problem that the patient has to deal with
during the entire perioperative period.REAPPRAISING STARLING:
CONCLUSIONS FOR CLINICAL PRACTICE
Natural proteins do not merely provide intravascu-








196 1.333204 3.482561 8714 [35]
227 1.831271 4.376654 8516 [40]
388 1.686437 4.3601.083 9812 [38]
217 1.469246 4.150451 9018 [40]
285 1.343806 3.501499 1710 [39&&]
1.379128 4.713868 3821 [36]
1.417209 4.818721 4326 [36]
yl starch; n, number of patients; n/a, not applicable; VL, volume loading.
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Intravenous fluidsvascular barrier already at very low concentrations.
This role can only insufficiently be taken over by
artificial colloids. However, albumin plasma con-
centrations of 1/4 of the physiological value appear
enough to make the system work. The rest of the
required intravascular oncotic pressure to achieve
plasma iso-oncoticity can, at least from a fluid-
physiological standpoint, be provided by any
macromolecule – the compartments will stay in
balance. Infusing a crystalloid leads to a distribution
by 80% of the infused amount towards the intersti-
tial space under any condition. Avoidance of intra-
vascular hypervolaemia promises to protect a
significant part of the vascular barrier.CONCLUSION
In every individual patient we should carefully con-
sider whether the pathophysiological price of choos-
ing crystalloids for substituting acute blood losses or
to prevent or to treat shock is worth paying. On the
contrary, systemic inflammation can have already
severely altered the vascular barrier, considerably
reducing the normally high intravascular volume
effect of colloids. Only the treating physician is able
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